GSK vs. IVV
GSK (GSK plc) is a stock, while IVV (iShares Core S&P 500 ETF) is S&P 500 fund tracking the S&P 500 Index. Over the past 10 years, GSK returned 4.03%/yr vs 15.17%/yr for IVV. At a 0.42 correlation, their price movements are largely independent.
Performance
GSK vs. IVV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GSK achieves a 6.18% return, which is significantly lower than IVV's 10.84% return. Over the past 10 years, GSK has underperformed IVV with an annualized return of 4.03%, while IVV has yielded a comparatively higher 15.17% annualized return.
GSK
- 1D
- -1.99%
- 1M
- -3.37%
- 6M
- 4.35%
- YTD
- 6.18%
- 1Y
- 38.69%
- 3Y*
- 18.60%
- 5Y*
- 4.89%
- 10Y*
- 4.03%
IVV
- 1D
- 0.34%
- 1M
- 1.61%
- 6M
- 8.94%
- YTD
- 10.84%
- 1Y
- 21.73%
- 3Y*
- 20.29%
- 5Y*
- 13.16%
- 10Y*
- 15.17%
GSK vs. IVV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GSK GSK plc | 6.18% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
IVV iShares Core S&P 500 ETF | 10.84% | 17.85% | 24.93% | 26.31% | -18.16% | 28.76% | 18.40% | 31.07% | -4.49% | 21.75% |
Correlation
The correlation between GSK and IVV is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since May 19, 2000 | 0.42 |
Over the past year, the correlation between GSK and IVV has dropped to 0.15 - well below their long-term average of 0.42, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSK vs. IVV — Risk / Return Rank
GSK
IVV
GSK vs. IVV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GSK plc (GSK) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GSK | IVV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.32 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.09 | 2.46 | -0.37 |
| Martin ratioReturn relative to average drawdown | 4.88 | 10.68 | -5.80 |
Loading charts...
Drawdowns
GSK vs. IVV - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.70%, roughly equal to the maximum IVV drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for GSK and IVV.
Loading charts...
Drawdown Indicators
| GSK | IVV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.70% | -55.25% | -0.45% |
Max Drawdown (1Y)Largest decline over 1 year | -18.63% | -8.89% | -9.74% |
Max Drawdown (3Y)Largest decline over 3 years | -28.46% | -18.75% | -9.71% |
Max Drawdown (5Y)Largest decline over 5 years | -50.10% | -24.53% | -25.57% |
Max Drawdown (10Y)Largest decline over 10 years | -50.10% | -33.90% | -16.20% |
Current DrawdownCurrent decline from peak | -14.89% | -0.77% | -14.12% |
Average DrawdownAverage peak-to-trough decline | -18.86% | -10.74% | -8.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.95% | 2.04% | +5.91% |
Volatility
GSK vs. IVV - Volatility Comparison
GSK plc (GSK) has a higher volatility of 7.88% compared to iShares Core S&P 500 ETF (IVV) at 4.03%. This indicates that GSK's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GSK | IVV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.88% | 4.03% | +3.85% |
Volatility (6M)Calculated over the trailing 6-month period | 19.61% | 10.04% | +9.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.11% | 12.58% | +14.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.28% | 17.01% | +8.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.91% | 18.05% | +4.86% |
Dividends
GSK vs. IVV - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 3.37%, more than IVV's 1.08% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GSK plc | 3.37% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
IVV iShares Core S&P 500 ETF | 1.08% | 1.17% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.85% | 2.21% | 1.75% | 2.01% | 2.27% |
Frequently Asked Questions
GSK and IVV have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GSK has higher volatility (7.88%) compared to IVV (4.03%). In terms of maximum drawdown, GSK dropped -55.70% vs IVV's -55.25%.
IVV currently has the higher Sharpe Ratio (1.74 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GSK and IVV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer